Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae

類似資料

• Reply to Chu et al., “Adoption of the New CLSI Fluoroquinolone Breakpoints for Enterobacteriaceae”
  著者:: Van, Tam T., 等
  出版事項: (2019)
• 2184. Effect of Adjusted CLSI Breakpoints on Center-wide Fluoroquinolone Susceptibilities for Enterobacteriaceae and Pseudomonas aeruginosa: Is It Time to Restrict Empiric Fluoroquinolone Use?
  著者:: Sansom, Sarah, 等
  出版事項: (2019)
• 1599. Clinical Outcomes for Patients Treated with Fluoroquinolones for Bacteremia Caused by Enterobacteriaceae Reclassified as Not Susceptible by Updated CLSI Breakpoints
  著者:: Fleischner, Zachary, 等
  出版事項: (2020)
• 1549. Impact of New Fluoroquinolone Breakpoints on Enterobacteriaceae Susceptibility Rates and Clinical Outcomes
  著者:: Pettit, Natasha N, 等
  出版事項: (2019)
• Susceptibility of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae According to the New CLSI Breakpoints
  著者:: Wang, Peng, 等
  出版事項: (2011)